대한한방내과학회지 (The Journal of Internal Korean Medicine)

대한한방내과학회 (The Society of Internal Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

항응고제 사용이 불가능했던 폐색전증 환자에 대한 혈부축어탕 치험 1례

A Case of Pulmonary Embolism Patient Contraindicated in the Use of Anticoagulants Improved by Administering Hyulbuchuko-tang

  • 하원정 (경희대학교 대학원 임상한의학과) ;
  • 이유진 (경희대학교 대학원 임상한의학과) ;
  • 김근영 (경희대학교 대학원 임상한의학과) ;
  • 조기호 (경희대학교 대학원 임상한의학과) ;
  • 문상관 (경희대학교 대학원 임상한의학과) ;
  • 정우상 (경희대학교 대학원 임상한의학과) ;
  • 권승원 (경희대학교 대학원 임상한의학과)
  • Ha, Won Jung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Yu Jin (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Geun Young (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Cho, Ki-Ho (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Moon, Sang-Kwan (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jung, Woo-Sang (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kwon, Seungwon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2021.03.25
  • 심사 : 2021.06.21
  • 발행 : 2021.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: This case report shows the effect of Hyulbuchuko-tang on a patient with a contraindication to anticoagulants who complained about dyspnea caused by pulmonary embolism (PE). Case report: A PE patient with dyspnea was treated with herbal medication, Hyulbuchuko-tang, for 28 days. Evaluations took place by assessing time for oxygen application time per day, follow-up chest CT, and D-dimer test results. Oxygen application time per day decreased, and oxygen therapy ended on the 14th day of Hyulbuchuko-tang treatment. Follow-up chest CT showed resolution of PE. The D-dimer level decreased on the 24th day and decreased more after 1 month later. Conclusion: This clinical case study suggests that Hyulbuchuko-tang might be effective in the resolution of PE and can be an option as a treatment for PE patients with contraindications to anticoagulants.

키워드

참고문헌

  1. Dantzker DR. Cardiopulmonary critical care, 2nd, Philadelphia: WB Sauders; 1991, p. 731-68.
  2. Manganelli D, Palla A, Donnamaria V, Giuntini C. Clinical features of pulmonary embolism: douts and certainties. Chest 1995;107(1):25S-32S. https://doi.org/10.1378/chest.107.1_Supplement.25S
  3. Kim YK. Current Management of Pulmonary Thromboembolism. The Kor J of Medicine 2013;84(5):659-69. https://doi.org/10.3904/kjm.2013.84.5.659
  4. Fauci AS, Harrison TR. Harrison's principles of internal medicine. 19th ed. New York: McGraw-Hill Medical; 2015, p. 1634-6.
  5. White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 2000;160(13):2033-41. https://doi.org/10.1001/archinte.160.13.2033
  6. Jang S, Kang BG, Ko MM, Jung J. Development of questionnaire for metabolic disease with blood stasis: A Delphi survey. Journal of Society of Preventive Korean Medicine 2018;22(3):83-9. https://doi.org/10.25153/spkom.2018.22.3.008
  7. Cha SI, Choi SH. Thrombolysis in Massive Pulmonary Embolism. Clin Exp Thromb Hemost 2017;3(1):8-11. https://doi.org/10.14345/ceth.17003
  8. Osita N.OkaforBSc, Diana A.Gorog. Endogenous Fibrinolysis: An Important Mediator of Thrombus Formation and Cardiovascular Risk. Journal of the American College of Cardiology 2015;65(16) :1683-99. https://doi.org/10.1016/j.jacc.2015.02.040
  9. 王淸任. 醫林改錯. 北京: 中國中醫藥出版社; 1995, p. 24-8.
  10. Lee MS, Roh SS, Lim RH, Song HC, Shin SS, Kim SH. Antithrombotic Activity and Protective Effects of hexane fraction of Kamihyulbuchukeotang (KHBCT) on brain injury by KCN and MCA occlusion. Kor J Pharmacongn 2000;31(4):373-82.
  11. Oh GS, Hong YW, Lee TK. The effect of Heulbuchuketang on endometriosis. Journal of Korean Medicine 1997;18(2):273-82.
  12. Han IS, Jang IS, Sun SH. Xuefuzhuyu Decoction for Essential Hypertension : Meta-Analysis and Systemic Review. J Int Korean Med 2018;39(6) :1150-67. https://doi.org/10.22246/jikm.2018.39.6.1150
  13. Kim YY, Cho HY, Kwon YJ, Cho SH, Hwang WW. A Case Study of Patient with Jung Choong, Gyeong Gye that Improved by Hyeolbuchukyeo-tang. J of Oriental Neurosychiatry 2009;20(3):249-59.
  14. Yang DS, Yang SJ, Cho SH, Yeo EJ, Park KM. Clinical Study of Kamitongkyung-tang's Effects on 3 Cases of Complications of Post-hysterectomy. The Journal of Korean Obstetrics and Gynecology 2011;24(4):205-12. https://doi.org/10.15204/JKOBGY.2011.24.4.205
  15. Kim YS, Park JH, Han YH, Jeon CY, Kim DW, Park SK, et al. The Effects of Hyulbuchukotang (HCE) on the Thrombosis Related Factors. Korean J Orient Int Med 2000;21(5):819-27.
  16. Kang JS, Park SH, Song MG, Ahn YM, Ahn SY, Lee BC. The Effect of Hyulbuchuko-tang on a Case with Deep Vein Thrombosis (DVT) and Intracranial Hemorrhage. Korean J Orient Int Med 2009;30(2):438-49.
  17. Lee MH, Hur HS, Kim KM, Kim YK. Case Study of a Deep-vein Thrombosis Patient Treated with Combinatorial Hyulbuchuko-tang. Korea J Orient Int Med 2016;37(2):315-21.
  18. Yang NY, Liu L, Tao WW, Duan JA, Liu XH, Huang SP. Antithrombotic lipids from Semen Persicae. Nat Prod Res 2011;25(17):1650-6. https://doi.org/10.1080/14786419.2011.568942
  19. Zhou X, Tang L, Xu Y, Zhou G, Wang Z. Towards a better understanding of medicinal uses of Carthamus tinctorius L. in traditional Chinese medicine: a phytochemical and pharmacological review. J Ethnopharmacol 2013;151(1):27-43. https://doi.org/10.1016/j.jep.2013.10.050
  20. Shin YJ, Park YK. Kor. Effects of different parts of Angelica gigasNakaion brain damages and neuronal death in transient middle artery occlusion/reperfusion-induced ischemic rats. J Herbology 2014;29(6):85-93. https://doi.org/10.6116/kjh.2014.29.6.85.
  21. Tripodi A. D-Dimer Testing in Laboratory Practice. Lab Med Online 2012;2(3):119-25. https://doi.org/10.3343/lmo.2012.2.3.119